Acrux Ltd has released a press release.
Commercialisation of Nitroglycerin Ointment
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Acrux
- Share Purchase Plan Offer Booklet
- Investor Presentation
- Share Placement successfully concluded and SPP launched
- FDA Approval - Nitroglycerin Ointment
- Trading Halt
Later from Acrux
- Investor Deck update, SPP Closes 18 December 2024, 5pm
- Acrux raises $1.34 million from SPP
- Launch of 90 gram pack size of Dapsone 5%, Gel in US
- Monthly Activities/Appendix 4C Cash Flow Report
- Acrux CEO announces plan to retire
Follow Acrux into a list and get an email when it puts out news.
Follow Acrux